Abstract
Heat-shock proteins (HSPs) have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS). In this study, we aimed to examine whether the serum levels of HSPs (HSP27, HSP70, and HSP90) are altered in patients with ALS. We included 58 patients diagnosed with ALS and 85 control individuals. Serum HSP levels of patients and controls were determined using enzyme-linked immunosorbent assay. The serum levels of HSP70 and HSP90 were significantly higher in patients than in controls. In contrast, serum levels of HSP27 did not differ significantly between the patient and control groups. Moreover, serum levels of HSP70 and HSP90 in patients remained high throughout the duration of the disease. Taken together, our findings suggest that HSPs might have a role in ALS progression throughout the course of the disease. Further studies are needed to clarify the role of HSPs in the pathogenesis of ALS.
Similar content being viewed by others
References
Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942–955
Adachi H, Karsuno M, Minamiyama M, Sang C, Pagoulatos G, Angelidis C et al (2003) Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J Neurosci 15:2203–2211
Katsuno M, Sang C, Dachi H, Minamiyama M, Waza M, Tanaka F et al (2005) Pharmacological induction of heat-shock proteins alleviates polyglutamine-mediated motor neuron disease. Proc Natl Acad Sci USA 102:16801–16806
Kalmar B, Lu CH, Greemsmith L (2014) The role of heat shock proteins in amyotrophic lateral sclerosis: the therapeutic potential of arimoclomol. Pharmacol Ther 141:40–54
Patel YJ, Payne Smith MD, de Belleroche J, Latchman DS (2005) Hsp27 and Hsp70 administered in combination have a potent protective effect against FALS-associated SOD1-mutant-induced cell death in mammalian neuronal cells. Brain Res Mol Brain Res 134:256–274
Bassan M, Zamostiano R, Gilade E, Davidson A, Wollman Y, Pitman J et al (1998) The identification of secreted heat shock 60-like protein from rat glial cells and a human neuroblastoma cell line. Neurosci Lett 250:37–40
Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegard J (2003) Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 42:235–238
Brooks BR, Miller RG, Swash M, Munsat TL (2001) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mon Neuron Disord 1:293–299
Cedarbaum JM, Stambler N (1997) Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials. J Neurol Sci 152:S1–S9
Beere HM (2004) “The stress of dying”: the role of heat shock proteins in the regulation of apoptosis. J Cell Sci 117:2641–2651
Synofzik M, Ronchi D, Keskin I, Basak AN, Wilhelm C, Gobbi C et al (2012) Mutant superoxide dismutase-1 indistinguishable from wild-type causes ALS. Hum Mol Genet 21:3568–3574
Münch C, O’Brien J, Bertolotti A (2011) Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells. Proc Natl Acad Sci USA 108:3548–3553
Bruening W, Roy J, Giasson B, Figlewicz DA, Mushynski WE, Durham HD (1999) Up-regulationof protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J Neurochem 72:693–699
Alvira S, Cuellar J, Rohl A, Yamamoto S, Itoh H, Alfonso C et al (2014) Structural characterization of the substrate transfer mechanism in HSP70/HSP90 folding machinery mediated by Hop. Nat Commun 5:5484
Currie RW, White FP (1981) Trauma-induced protein in rat tissues: a physiological role for a “heat shock” protein. Science 214:72–73
Krueger-Naug AM, Hopkins DA, Armstrong JN, Plumier JC, Currie RW (2000) Hyperthermic induction of the 27-kDa heat shock protein (Hsp27) in neuroglia and neurons of the rat central nervous system. J Comp Neurol 428:495–510
Pardridge WM (2005) The blood–brain barrier: bottleneck in brain drug development. NeuroRx 2:3–14
Abbott NJ, Rönnbäck L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53
Banks WA, Kastin AJ, Broadwell RD (1995) Passage of cytokines across the blood–brain barrier. Neuroimmunomodulation 2:241–248
Yang J, Bridges K, Chen KY, Liu AY (2008) Riluzole increase the amount of latent HSF1 for an amplified heat shock response and cytoprotection. PLoS One 3:e2864
Li D, Duncan RF (1995) Transient acquired thermotolerane in Drosophila, correlated with rapid degradation of HSP70 during recovery. Eur J Biochem 231:454–465
Mizzen LA, Welch WJ (1988) Characterization of the thermotolerant cell. I. Effects on protein synthesis activity and the regulation of heat-shock protein 70 expression. J Cell Biol 106:1105–1116
Labra J, Menon P, Byth K, Morrison S, Vucic S (2015) Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry. doi:10.1136/jnnp-2015-310998. [Epub ahead of print]
Namba Y, Tomonaga M, Ohtsuka K, Oda M, Ikeda K (1991) HSP70 is associated with abnormal cytoplasmic inclusions characteristic of neurodegenerative disease. No To Shinkei 43:57–60
Acknowledgments
This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan by a Grant-in-Aid from the Promotion Project of Education, Research, and Medical Care.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Miyazaki, D., Nakamura, A., Hineno, A. et al. Elevation of serum heat-shock protein levels in amyotrophic lateral sclerosis. Neurol Sci 37, 1277–1281 (2016). https://doi.org/10.1007/s10072-016-2582-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2582-1